Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
Clinical and genotypic pattern of multidrug resistant tuberculosis isolated from extrapulmonary tuberculosis cases in tertiary care hospitals in northern India Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Multidrug resistant tuberculosis in non HIV patients Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007
Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007
Study of drug resistance profile in Multidrug resistant tuberculosis (MDR TB) patients attending a tertiary care hospital at Mumbai. Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Outcomes of patients with multidrug resistant tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005
Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, India Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Development of multi-drug resistant tuberculosis among patients treated with category II regimen: A lung center of the Philippines experience Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India. Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002
Comparative analysis between multidrug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) in HIV(+) patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Evaluation of the multidrug resistant TB in children with HIV infection Source: Eur Respir J 2004; 24: Suppl. 48, 439s Year: 2004
A tale of two settings: The role of the Beijing genotype in the rise of multidrug resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Multidrug resistance tuberculosis (MDR-TB) in the north east area of Tunisia Source: Eur Respir J 2007; 30: Suppl. 51, 700s Year: 2007